论文部分内容阅读
人们普遍认为在发展中国家需要将乙型肝炎疫苗纳入国家免疫接种计划,但是由于疫苗成本高,迄今仍阻碍着乙型肝炎免疫计划的实行。有人论证,当乙型肝炎疫苗的价格降到1美元/剂以下时,其免疫计划在发展中国家才有可行性。为了确定疫苗的最低成本,在一人口约为5000万的发展中国家开展了生产血源性乙型肝炎疫苗的研究工作。作者对所获得的资料进行了详细的财务方面的分析。投资费用:大批生产车间的设备、建筑
It is generally accepted that hepatitis B vaccine needs to be integrated into national vaccination programs in developing countries, but so far the practice of hepatitis B immunization programs has been hampered by the high cost of vaccines. Some have argued that when the price of hepatitis B vaccine drops below $ 1 / dose, its immunization program is only feasible in developing countries. In order to determine the minimum cost of vaccines, research into the production of blood-borne hepatitis B vaccines was conducted in a developing country population of about 50 million. The author conducted a detailed financial analysis of the information obtained. Investment costs: a large number of production workshop equipment, construction